Sunesis Pharmaceuticals (
SNSS) is a biopharmaceutical company engaged in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. This stock closed up 1.4% to $5.61 in Tuesday's trading session.
Tuesday's Range: $5.38-$5.62
52-Week Range: $2.30-$6.85
Tuesday's Volume: 614,000
Three-Month Average Volume: 345,849
>>5 Stocks Triggering Breakout Trades
From a technical perspective, SNSS trended modestly higher here right above its 50-day moving average of $5.35 with above-average volume. This move is quickly pushing shares of SNSS within range of triggering a major breakout trade. That trade will hit if SNSS manages to take out some near-term overhead resistance levels at $5.75 to $6.05 with high volume.
Traders should now look for long-biased trades in SNSS as long as it's trending above its 50-day at $5.35 and then once it sustains a move or close above those breakout levels with volume that hits near or above 345,849 shares. If that breakout triggers soon, then SNSS will set up to re-test or possibly take out its next major overhead resistance levels at $6.54 to its 52-week high at $6.85. Any high-volume move above those levels will then put $7 to $8 into range for shares of SNSS.
To see more stocks that are making notable moves higher today, check out the
Stocks Under $10 Moving Higher
portfolio on Stockpickr.
-- Written by Roberto Pedone in Delafield, Wis.
Follow Stockpickr on
and become a fan on
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts